Center for Reproductive Sciences, San Francisco, CA, USA.
Department of Obstetrics and Gynecology, University of California, San Francisco, CA, USA.
Endocr Rev. 2021 May 25;42(3):219-258. doi: 10.1210/endrev/bnaa034.
In May 2014, the National Institutes of Health (NIH) stated its intent to "require applicants to consider sex as a biological variable (SABV) in the design and analysis of NIH-funded research involving animals and cells." Since then, proposed research plans that include animals routinely state that both sexes/genders will be used; however, in many instances, researchers and reviewers are at a loss about the issue of sex differences. Moreover, the terms sex and gender are used interchangeably by many researchers, further complicating the issue. In addition, the sex or gender of the researcher might influence study outcomes, especially those concerning behavioral studies, in both animals and humans. The act of observation may change the outcome (the "observer effect") and any experimental manipulation, no matter how well-controlled, is subject to it. This is nowhere more applicable than in physiology and behavior. The sex of established cultured cell lines is another issue, in addition to aneuploidy; chromosomal numbers can change as cells are passaged. Additionally, culture medium contains steroids, growth hormone, and insulin that might influence expression of various genes. These issues often are not taken into account, determined, or even considered. Issues pertaining to the "sex" of cultured cells are beyond the scope of this Statement. However, we will discuss the factors that influence sex and gender in both basic research (that using animal models) and clinical research (that involving human subjects), as well as in some areas of science where sex differences are routinely studied. Sex differences in baseline physiology and associated mechanisms form the foundation for understanding sex differences in diseases pathology, treatments, and outcomes. The purpose of this Statement is to highlight lessons learned, caveats, and what to consider when evaluating data pertaining to sex differences, using 3 areas of research as examples; it is not intended to serve as a guideline for research design.
2014 年 5 月,美国国立卫生研究院(NIH)表示有意“要求申请人在涉及动物和细胞的 NIH 资助研究的设计和分析中考虑性别作为生物学变量(SABV)”。从那时起,包含动物的拟议研究计划通常会声明将同时使用两种性别;然而,在许多情况下,研究人员和评审人员对性别差异问题感到困惑。此外,许多研究人员混用性别和性别这两个术语,进一步使问题复杂化。此外,研究人员的性别可能会影响研究结果,尤其是那些涉及动物和人类行为的研究结果。观察行为本身可能会改变结果(“观察者效应”),并且任何实验操作,无论控制得多么好,都可能受到影响。这在生理学和行为学中最为适用。除了非整倍体外,已建立的培养细胞系的性别也是一个问题;随着细胞的传代,染色体数量可能会发生变化。此外,培养基中含有类固醇、生长激素和胰岛素,这些物质可能会影响各种基因的表达。这些问题通常没有被考虑、确定,甚至被忽视。与培养细胞的“性别”有关的问题不在本声明的范围内。然而,我们将讨论影响基础研究(使用动物模型)和临床研究(涉及人类受试者)中性别和性别的因素,以及在一些常规研究性别差异的科学领域中,影响性别和性别的因素。基础生理学中的性别差异及其相关机制为理解疾病病理、治疗和结果中的性别差异奠定了基础。本声明的目的是强调从三个研究领域的例子中吸取的经验教训、注意事项和在评估与性别差异相关的数据时需要考虑的因素;它不是设计研究的指南。